A MECHANISTIC STUDY TO EXPLAIN THE SURVIVAL BENEFIT OF CHEMO-HORMONAL THERAPY IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

$533,409FY2016Department of DefenseDOD

Dana-Farber Cancer Institute, Inc.

Investigators